Catalyst

Slingshot members are tracking this event:

Clovis' (CLVS) European Marketing Authorization Application (MAA) Submission for Rucaparib in ADHD Planned for Q4 2016

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
CLVS

100%
Slingshot Insights Explained
Catalyst Date
Occurred on:
Nov 03, 2016
Occurred Source:
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords European Marketing Authorization Application, Rucaparib, Adhd